Printer Friendly
The Free Library
14,679,458 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Animas Corporation Receives FDA 510k Clearance for Its Diabetes Management Software System.


Business Editors/Health/Medical Writers

FRAZER, Pa.--(BUSINESS WIRE)--June 19, 2003

Animas Corporation, a manufacturer of insulin infusion pumps infusion pump A device designed to deliver drugs and/or 'biologicals', at low doses and at a constant or controllable rate; ↑ rates of delivery in such devices may be associated with local hemolysis, compromising the potential benefits of a calibrated delivery  and other products for patients with insulin-requiring diabetes, announced today that it has received US Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) 510(k) clearance to market ezManager Plus.

ezManager Plus, the first software system of its kind to receive FDA 510(k) clearance, differs from other available systems with its comprehensive food database, carbohydrate calculator, and ability to accept download information from both the Animas IR 1000 insulin pump insulin pump
n.
A portable device for people with diabetes that injects insulin at programmed intervals in order to regulate blood sugar levels.
 and a variety of blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence  meters.

This software system, with both a Palm-OS and desktop module, is designed to help people better manage their diabetes and help reduce the time healthcare professionals need to spend helping patients manage diabetes. With this intuitive program, patients can:

-- Access a database of more than 3,000 different foods,

including fast food restaurants and customized favorites,

-- Record daily activity on a personal digital assistant (PDA (Personal Digital Assistant) A handheld computer for managing contacts, appointments and tasks. It typically includes a name and address database, calendar, to-do list and note taker, which are the functions in a personal information manager (see PIM). ),

-- Automatically calculate insulin needs for carbohydrate intake

and blood glucose readings,

-- Download and electronically send insulin pump history, blood

glucose meter A glucose meter (or glucometer) is a medical device for determining the approximate concentration of glucose in the blood. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or with proneness to hypoglycemia.  and PDA records, and

-- Do trending analysis and obtain other statistical analysis.

Commenting on the FDA clearance, Dr. Katherine Crothall, Animas' CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  said, "Managing diabetes properly is very time-intensive for patients and their healthcare teams. Patients need to adjust their insulin intake based upon the carbohydrate content of their meal and current blood glucose readings, necessitating patients thumbing through food databases and performing multi-step computations. Many patients simply make wild guesses. ezManager Plus removes much of the guesswork and significantly simplifies the time-intensive computations.

"We are also committed to developing tools that reduce the strain on the already over-burdened healthcare system. The reports available from ezManager Plus give patients and the healthcare team a comprehensive view of important parameters of diabetes management This article is about the management of diabetes mellitus. For more on the disease itself see diabetes mellitus.
Diabetes is a chronic disease with no cure as of 2007. It is associated with an impaired glucose cycle, altering metabolism.
 and allow healthcare professionals to focus more efficiently on developing treatment plans for their patients," Dr. Crothall explains.

About Animas Corporation: Animas, a leading maker of insulin infusion pumps and related products, is dedicated to improving diabetes management and making insulin pump therapy easier for patients with insulin-requiring diabetes and healthcare professionals through product innovation, exemplary customer support and superior customer education. For more information on Animas, visit www.animascorp.com or call Animas Corporation at 877-937-7867.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 19, 2003
Words:380
Previous Article:S&P Global Credit Markets Digest.
Next Article:Axonyx Announces Steering Committee for Phenserine in Alzheimer's Disease Clinical Trials.
Topics:



Related Articles
Enhancing efficiency: step by step. (medical law)
Animas Corporation Receives Ernst & Young Entrepreneur of the Year Award.
Animas IR 1200 - the World's Smallest Full Feature Insulin Pump - Receives FDA Approval.
Israeli Ministry of Health Approves Animas IR 1200 Insulin Pump for Distribution.
Health Canada Approves Animas IR 1200 Insulin Pump for Distribution.
Animas Announces Notification to IR 1200 Users, Reaffirms Guidance.
Animas Acquires Technology for Disposable Insulin Micro-pumps and Micro-needles.
Animas Corporation Increases Revenue Guidance for 2004, Provides Initial Guidance for 2005, and Announces IR 1250 Approval By FDA.
BRIEFCASE.(Business)
Antitrust Approval Received for Acquisition of Animas Corporation by Johnson & Johnson Subsidiary.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles